These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11294932)

  • 1. Comparisons of patient self-report, neurologic examination, and functional impairment in MS.
    Hoogervorst EL; van Winsen LM; Eikelenboom MJ; Kalkers NF; Uitdehaag BM; Polman CH
    Neurology; 2001 Apr; 56(7):934-7. PubMed ID: 11294932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.
    Hoogervorst EL; Zwemmer JN; Jelles B; Polman CH; Uitdehaag BM
    Mult Scler; 2004 Oct; 10(5):569-74. PubMed ID: 15471375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One year changes in disability in multiple sclerosis: neurological examination compared with patient self report.
    Hoogervorst EL; Eikelenboom MJ; Uitdehaag BM; Polman CH
    J Neurol Neurosurg Psychiatry; 2003 Apr; 74(4):439-42. PubMed ID: 12640058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite.
    Hoogervorst EL; Kalkers NF; Cutter GR; Uitdehaag BM; Polman CH
    Mult Scler; 2004 Feb; 10(1):55-60. PubMed ID: 14760953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosis.
    Hoogervorst EL; Kalkers NF; van Winsen LML ; Uitdehaag BM; Polman CH
    Mult Scler; 2001 Oct; 7(5):335-9. PubMed ID: 11724450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study validating changes in the multiple sclerosis functional composite.
    Hoogervorst EL; Kalkers NF; Uitdehaag BM; Polman CH
    Arch Neurol; 2002 Jan; 59(1):113-6. PubMed ID: 11790238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How similar are commonly combined criteria for EDSS progression in multiple sclerosis?
    Kragt JJ; Nielsen IM; van der Linden FA; Uitdehaag BM; Polman CH
    Mult Scler; 2006 Dec; 12(6):782-6. PubMed ID: 17263007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
    Ozakbas S; Cagiran I; Ormeci B; Idiman E
    J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The INTERMED: a screening instrument to identify multiple sclerosis patients in need of multidisciplinary treatment.
    Hoogervorst EL; de Jonge P; Jelles B; Huyse FJ; Heeres I; van der Ploeg HM; Uitdehaag BM; Polman CH
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):20-4. PubMed ID: 12486260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Guy's Neurological Disability Scale as a screening tool for cognitive impairment in multiple sclerosis.
    Akatani R; Chihara N; Tachibana H; Koto S; Kowa H; Kanda F; Matsumoto R; Toda T
    Mult Scler Relat Disord; 2019 Oct; 35():272-275. PubMed ID: 31442905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
    Ozakbas S; Ormeci B; Idiman E
    J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MS functional composite: relation to disease phenotype and disability strata.
    Kalkers NF; de Groot V; Lazeron RH; Killestein J; Adèr HJ; Barkhof F; Lankhorst GJ; Polman CH
    Neurology; 2000 Mar; 54(6):1233-9. PubMed ID: 10746590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Brazilian version of Guy's neurological disability scale.
    Araujo CR; Simão LM; Ybarra MI; Faria NV; Botelho CM; Moreira MA; Teixeira AL; Lana-Peixoto MA
    Arq Neuropsiquiatr; 2007 Sep; 65(3A):615-8. PubMed ID: 17876401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Guy's Neurological Disability Scale in patients with multiple sclerosis: a clinical evaluation of its reliability and validity.
    Rossier P; Wade DT
    Clin Rehabil; 2002 Feb; 16(1):75-95. PubMed ID: 11837529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life.
    Miller DM; Rudick RA; Cutter G; Baier M; Fischer JS
    Arch Neurol; 2000 Sep; 57(9):1319-24. PubMed ID: 10987899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses.
    Bin Sawad A; Seoane-Vazquez E; Rodriguez-Monguio R; Turkistani F
    Curr Med Res Opin; 2016 Dec; 32(12):1969-1974. PubMed ID: 27603119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite.
    Hobart J; Kalkers N; Barkhof F; Uitdehaag B; Polman C; Thompson A
    Mult Scler; 2004 Feb; 10(1):41-6. PubMed ID: 14760951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric properties of the Italian version of the Guy's Neurological Disability Scale.
    Pappalardo A; Patti F
    Funct Neurol; 2010; 25(4):223-33. PubMed ID: 21388584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MSCopilot: New smartphone-based digital biomarkers correlate with Expanded Disability Status Scale scores in people with Multiple Sclerosis.
    Tanoh IC; Maillart E; Labauge P; Cohen M; Maarouf A; Vukusic S; Donzé C; Gallien P; De Sèze J; Bourre B; Moreau T; Louapre C; Vallée M; Bieuvelet S; Klaeylé L; Argoud AL; Zinaï S; Tourbah A
    Mult Scler Relat Disord; 2021 Oct; 55():103164. PubMed ID: 34352512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of multi-domain patient reported outcome measures for detecting clinical disease progression in multiple sclerosis.
    van 't Hullenaar CAA; Coerver E; Kalkers NF; van Kempen Z; Koch M; Uitdehaag BMJ; Killestein J; Strijbis EMM
    Mult Scler Relat Disord; 2021 Oct; 55():103165. PubMed ID: 34404022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.